Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized and Observer-blinded Study to Evaluate the Cumulative Irritation and Contact Sensitizing Potential of One Finished Test Product

NCT02224625 is registered in ClinicalTrials.gov with Medline Industries as lead sponsor.

NCT NCT02224625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02224625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized and Observer-blinded Study to Evaluate the Cumulative Irritation and Contact Sensitizing Potential of One Finished Test Product
Lead sponsor
Medline Industries
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2014
Completion date
June 30, 2015
Enrollment
249 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

surgery